Cargando…

Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?

Diabetic polyneuropathy (DPN) encompasses multiple syndromes with a common pathogenesis. Glycemic control shows a limited correlation with DPN, arguing in favor of major involvement of other factors, one of which is alterations of lipid and lipoprotein metabolism. Consistent associations have been f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez-Matos, M. C., Morales-Alvarez, M. C., Mendivil, C. O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278202/ https://www.ncbi.nlm.nih.gov/pubmed/28191471 http://dx.doi.org/10.1155/2017/6943851

Ejemplares similares

Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach
por: Coutinho, Maria Francisca, et al.
Publicado: (2020)

Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review
por: Amaya-Montoya, Mateo, et al.
Publicado: (2020)

The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina
por: Oshitari, Toshiyuki
Publicado: (2021)

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy
por: Fledrich, R., et al.
Publicado: (2018)

Diabetic Neuropathy and Oxidative Stress: Therapeutic Perspectives
por: Hosseini, Asieh, et al.
Publicado: (2013)

Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy
por: Kabir, Md. Tanvir, et al.
Publicado: (2021)

Mitochondrial Dysfunction and Therapeutic Targets in Auditory Neuropathy
por: Feng, Baoyi, et al.
Publicado: (2020)

Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?
por: Buonfiglio, Francesco, et al.
Publicado: (2023)

Conventional deep pressure algometry is not suitable for clinical assessment of nociception in painless diabetic neuropathy
por: Chantelau, Ernst A.
Publicado: (2016)

Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
por: Alam, Manzar, et al.
Publicado: (2021)

Diabetic neuropathy research: from mouse models to targets for treatment
por: Pham, Vuong M., et al.
Publicado: (2019)

Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy
por: Fan, Baoyan, et al.
Publicado: (2020)

Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy
por: So, Wei Zheng, et al.
Publicado: (2022)

Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy()
por: Ganesh Yerra, Veera, et al.
Publicado: (2013)

Tolerating diabetes: an alternative therapeutic approach for diabetic neuropathy
por: Calcutt, Nigel A
Publicado: (2010)

PGC1α: an emerging therapeutic target for chemotherapy-induced peripheral neuropathy
por: Zhai, Mingzhu, et al.
Publicado: (2023)

Diabetic Corneal Neuropathy
por: Mansoor, Hassan, et al.
Publicado: (2020)

Diabetes: how to manage diabetic peripheral neuropathy
por: Gandhi, Megha, et al.
Publicado: (2022)

Therapeutic alternatives in painful diabetic neuropathy: a meta-analysis of randomized controlled trials
por: Vilar, Samuel, et al.
Publicado: (2018)

Therapeutic Options in Hereditary Optic Neuropathies
por: Amore, Giulia, et al.
Publicado: (2020)

Using Corneal Confocal Microscopy to Identify Therapeutic Agents for Diabetic Neuropathy
por: Jolivalt, Corinne G., et al.
Publicado: (2022)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Neuroinflammation and Oxidative Stress in Diabetic Neuropathy: Futuristic Strategies Based on These Targets
por: Sandireddy, Reddemma, et al.
Publicado: (2014)

Lipid A as a Drug Target and Therapeutic Molecule
por: Joo, Sang Hoon
Publicado: (2015)

Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
por: Wang, Xiaotong, et al.
Publicado: (2018)

Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus
por: Toloza, Freddy J. K., et al.
Publicado: (2018)

Updates in diabetic peripheral neuropathy
por: Juster-Switlyk, Kelsey, et al.
Publicado: (2016)

Neuropathy and Diabetic Foot Syndrome
por: Volmer-Thole, Maren, et al.
Publicado: (2016)

Skin AGEs and diabetic neuropathy
por: Papachristou, Stella, et al.
Publicado: (2021)

Characterization of the Interaction of Neuropathy Target Esterase with the Endoplasmic Reticulum and Lipid Droplets
por: Chang, Pingan, et al.
Publicado: (2019)

Diabetic Neuropathy and Gait: A Review
por: Alam, Uazman, et al.
Publicado: (2017)

Diabetic Corneal Neuropathy: Pathogenic Mechanisms and Therapeutic Strategies
por: Zhou, Ting, et al.
Publicado: (2022)

Pathogenesis of Painful Diabetic Neuropathy
por: Aslam, Amir, et al.
Publicado: (2014)

Diagnosing peripheral neuropathy in South‐East Asia: A focus on diabetic neuropathy
por: Malik, Rayaz A, et al.
Publicado: (2020)

Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-κB in diabetic peripheral neuropathy
por: Li, Jia, et al.
Publicado: (2019)

Therapeutic compounds targeting Lipid II for antibacterial purposes
por: Malin, Jakob J, et al.
Publicado: (2019)

Lipid metabolism in tumor microenvironment: novel therapeutic targets
por: Liu, Xingkai, et al.
Publicado: (2022)

Lipid-loaded macrophages as new therapeutic target in cancer
por: Marelli, Giulia, et al.
Publicado: (2022)

Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
por: Vitulo, Manuela, et al.
Publicado: (2023)

Adenosine kinase as a therapeutic target in traumatic optic neuropathy
por: Ahmad, Saif, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_el84s5fps4ho8kcjjeb5cic5vr